Boška Hrvačić

473 total citations
20 papers, 271 citations indexed

About

Boška Hrvačić is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Boška Hrvačić has authored 20 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Boška Hrvačić's work include Asthma and respiratory diseases (6 papers), Respiratory and Cough-Related Research (4 papers) and Immune Response and Inflammation (4 papers). Boška Hrvačić is often cited by papers focused on Asthma and respiratory diseases (6 papers), Respiratory and Cough-Related Research (4 papers) and Immune Response and Inflammation (4 papers). Boška Hrvačić collaborates with scholars based in Croatia, Austria and United States. Boška Hrvačić's co-authors include Berislav Bošnjak, Vesna Eraković Haber, Martina Bosnar, Ines Glojnarić, Željko Ferenčić, Michael J. Parnham, Snježana Čužić, Denis Polančec, Milan Mesić and Karmen Brajša and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Boška Hrvačić

20 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boška Hrvačić Croatia 9 83 65 61 55 53 20 271
Fugui Yan China 10 73 0.9× 90 1.4× 43 0.7× 36 0.7× 108 2.0× 21 266
Neeraj Pal Singh India 7 130 1.6× 113 1.7× 162 2.7× 47 0.9× 41 0.8× 22 342
Akitaka Iwagaki Japan 11 141 1.7× 120 1.8× 73 1.2× 123 2.2× 82 1.5× 20 414
L R Whittaker United States 5 98 1.2× 113 1.7× 126 2.1× 34 0.6× 68 1.3× 11 355
Scott A. Hoselton United States 14 104 1.3× 129 2.0× 237 3.9× 72 1.3× 82 1.5× 26 451
Jin Jong Bong South Korea 12 66 0.8× 31 0.5× 48 0.8× 25 0.5× 91 1.7× 22 380
Bodo Wonnenberg Germany 12 87 1.0× 125 1.9× 66 1.1× 39 0.7× 148 2.8× 15 395
C.Allen Bruce United States 12 99 1.2× 92 1.4× 214 3.5× 15 0.3× 71 1.3× 14 440
H. G. de Vries Netherlands 7 64 0.8× 19 0.3× 32 0.5× 48 0.9× 75 1.4× 9 274
Hugues Wallemacq Belgium 4 102 1.2× 249 3.8× 79 1.3× 33 0.6× 67 1.3× 6 397

Countries citing papers authored by Boška Hrvačić

Since Specialization
Citations

This map shows the geographic impact of Boška Hrvačić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boška Hrvačić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boška Hrvačić more than expected).

Fields of papers citing papers by Boška Hrvačić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boška Hrvačić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boška Hrvačić. The network helps show where Boška Hrvačić may publish in the future.

Co-authorship network of co-authors of Boška Hrvačić

This figure shows the co-authorship network connecting the top 25 collaborators of Boška Hrvačić. A scholar is included among the top collaborators of Boška Hrvačić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boška Hrvačić. Boška Hrvačić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hrvačić, Boška, et al.. (2022). Retrospektivna procjena učinka nintedaniba u mišjem modelu plućne fibroze. Veterinarska stanica. 54(4). 395–406. 1 indexed citations
4.
Haber, Vesna Eraković, Snježana Čužić, Boška Hrvačić, et al.. (2015). Claudin expression in animal models of IBD and human disease. SHILAP Revista de lepidopterología. 2(2). 66–66. 3 indexed citations
5.
Hrvačić, Boška, et al.. (2014). Relative potencies of three glucocorticoids to induce hypoplasia of the physis and concomitant biochemical alterations in the rat. Drug and Chemical Toxicology. 38(3). 272–277. 1 indexed citations
6.
Bosnar, Martina, et al.. (2013). The histone-deacetylase-8 selective inhibitor PCI-34051 enhances IFN-λ production in vitro and reduces inflammation in mouse models of rhinoviral infection and rhinovirus-induced exacerbations of asthma in vivo. 42. 1972. 2 indexed citations
7.
Hrvačić, Boška, et al.. (2013). Synthesis and Anti-inflammatory Activity of Novel Furochromenes. Croatica Chemica Acta. 86(3). 253–264. 12 indexed citations
8.
Jelić, Dubravko, Boška Hrvačić, Karmen Brajša, et al.. (2012). Porphyrins as new endogenous anti-inflammatory agents. European Journal of Pharmacology. 691(1-3). 251–260. 15 indexed citations
9.
Hrvačić, Boška, Martina Bosnar, Snježana Čužić, et al.. (2012). Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories. Translational research. 160(2). 137–145. 10 indexed citations
10.
Kos, Vesna Munić, Jovica Ralić, Barbara Stanić, et al.. (2012). Macrolactonolides: A novel class of anti-inflammatory compounds. Bioorganic & Medicinal Chemistry. 21(1). 321–332. 11 indexed citations
11.
Bosnar, Martina, Goran Kragol, Sanja Koštrun, et al.. (2012). N′-Substituted-2′-O,3′-N-carbonimidoyl Bridged Macrolides: Novel Anti-inflammatory Macrolides without Antimicrobial Activity. Journal of Medicinal Chemistry. 55(13). 6111–6123. 23 indexed citations
12.
Hrvačić, Boška, et al.. (2011). Immunomodulatory effects of azithromycin on serum amyloid A production in lipopolysaccharide-induced endotoxemia in mice. The Journal of Antibiotics. 64(7). 515–517. 7 indexed citations
13.
Bošnjak, Berislav, et al.. (2010). Cage enrichment with paper tissue, but not plastic tunnels, increases variability in mouse model of asthma. Laboratory Animals. 45(2). 121–123. 8 indexed citations
14.
Bosnar, Martina, Snježana Čužić, Berislav Bošnjak, et al.. (2010). Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia. International Immunopharmacology. 11(4). 424–434. 49 indexed citations
15.
Bošnjak, Berislav, Snježana Čužić, Željko Ferenčić, et al.. (2009). Intranasal challenge with increasing ovalbumin doses differently affects airway hyperresponsiveness and inflammatory cell accumulation in mouse model of asthma. Inflammation Research. 58(11). 773–781. 4 indexed citations
16.
Hrvačić, Boška, Berislav Bošnjak, Martina Bosnar, et al.. (2009). Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma. European Journal of Pharmacology. 616(1-3). 236–243. 20 indexed citations
17.
Hrvačić, Boška, et al.. (2006). Applicability of an Ultrasonic Nebulization System for the Airways Delivery of Beclomethasone Dipropionate in a Murine Model of Asthma. Pharmaceutical Research. 23(8). 1765–1775. 16 indexed citations
18.
Bošnjak, Berislav, Boška Hrvačić, Martina Bosnar, et al.. (2006). Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. European Journal of Pharmacology. 539(1-2). 131–138. 77 indexed citations
19.
Bošnjak, Berislav, Maša Katić, Boška Hrvačić, Z Zupanovic, & Marija Poljak‐Blaži. (2004). Effect of Ferric Sorbitol Citrate (FSC) Administration on NF‐κB in Macrophages and Spleen Cells of Rats. Immunopharmacology and Immunotoxicology. 26(1). 43–52. 1 indexed citations
20.
Poljak‐Blaži, Marija, Boška Hrvačić, Z Zupanovic, et al.. (2003). Differing effects of two iron compounds on experimental arthritis, TNF-α levels and immune response in mice. International Immunopharmacology. 3(13-14). 1743–1749. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026